Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/16/20 → 10/16/23 |
Funding
- Medpace Clinical Research LLC (Prot #ME-522-001)
- MEI Pharma, Inc. (Prot #ME-522-001)
Prot #ME-522-001 : A Phase 1, Open-Label, Study of Voruciclib in Subjects with Relapsed and/or Refractory B-Cell Malignancies or Acute Myeloid Leukemia After Failure of Prior Standard Therapies
- Frankfurt, Olga (PD/PI)
Project: Research project